Cytokinetics Incorporated (CYTK) Gained 6.26% or 0.53 To Price $9.0 On Tuesday


Cytokinetics Incorporated (CYTK) gained 6.26% or 0.53 to $9.0. It is approximately 412603 shares traded, which is 65.39% compare to the average total volume 630979. The market cap of CYTK is $498.36 million. The year to date change is 30.45%. The 52 week price range is from $5.75 to $10.44. Price of CYTK have changed -0.24% during last week. It have changed -3.20% over last month, 26.42% over last 3 months, 18.63% over last 6 months and 17.64% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CYTK is 7.81. It is -13.22% below current price. The 200-day Moving Averages for CYTK is 7.64. It is -15.11% below current price. The 52-week High is 10.44. It is 16.00% from the current price. The 52-week Low is 5.75. It is -36.11% from current price.

There are some statistics of CYTK. It is has market cap $498.36 million. The share outstanding is 55.37 million. The average volume is 630979. The percent of top 15 Institution holding is 107.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CYTK is -156.57%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CYTK is -42.01%.


Tags:

Share this post